Exploring Immunotherapies in Development to Achieve a Functional Cure for Chronic HBV

Time: 11:00 am
day: Day Two


• Assessing mechanisms of action currently in development for chronic HBV

• What can we learn from progress in developing immunotherapies to inform future directions of dug development?

• Creating synergy while balancing therapeutic response and safety in combination therapies